메뉴 건너뛰기




Volumn 13, Issue 11-12, 2008, Pages 543-550

A case study of lean drug discovery: from project driven research to innovation studios and process factories

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

EID: 44649123594     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2008.03.011     Document Type: Review
Times cited : (43)

References (18)
  • 1
    • 33947543573 scopus 로고    scopus 로고
    • Research & market strategy: how choice of drug discovery approach can affect market position
    • Sams-Dodd F. Research & market strategy: how choice of drug discovery approach can affect market position. Drug Discov. Today 12 (2007) 314-318
    • (2007) Drug Discov. Today , vol.12 , pp. 314-318
    • Sams-Dodd, F.1
  • 2
    • 33845760008 scopus 로고    scopus 로고
    • China's unique position in discovery and preclinical research
    • Boutellier R., and Ullman F. China's unique position in discovery and preclinical research. Drug Discov. Today 12 (2007) 4-7
    • (2007) Drug Discov. Today , vol.12 , pp. 4-7
    • Boutellier, R.1    Ullman, F.2
  • 3
    • 33847613935 scopus 로고    scopus 로고
    • Big pharma slims down to bolster productivity
    • Owens J. Big pharma slims down to bolster productivity. Nat. Rev. Drug Discov. 6 (2007) 173-174
    • (2007) Nat. Rev. Drug Discov. , vol.6 , pp. 173-174
    • Owens, J.1
  • 5
    • 34548314048 scopus 로고    scopus 로고
    • Minimizing leakage of value from R&D alliances
    • Jones A. Minimizing leakage of value from R&D alliances. Nat. Rev. Drug Discov. 6 (2007) 711-719
    • (2007) Nat. Rev. Drug Discov. , vol.6 , pp. 711-719
    • Jones, A.1
  • 6
    • 44649184057 scopus 로고    scopus 로고
    • De-risking the portfolio: evolving portfolio management to deliver what it is capable of in terms of truly assessing both economic potential and technical risk
    • Phacilitate
    • Clark D.A. De-risking the portfolio: evolving portfolio management to deliver what it is capable of in terms of truly assessing both economic potential and technical risk. R&D Leaders' Forum Autumn 2007 (2007), Phacilitate
    • (2007) R&D Leaders' Forum Autumn 2007
    • Clark, D.A.1
  • 9
    • 13844276627 scopus 로고    scopus 로고
    • Target-based drug discovery: is something wrong?
    • Sams-Dodd F. Target-based drug discovery: is something wrong?. Drug Discov. Today 10 (2005) 139-147
    • (2005) Drug Discov. Today , vol.10 , pp. 139-147
    • Sams-Dodd, F.1
  • 10
    • 1242276509 scopus 로고    scopus 로고
    • Measuring R&D productivity: complementing the picture by focusing on research activities
    • Karlsson M., et al. Measuring R&D productivity: complementing the picture by focusing on research activities. Technovation 24 (2004) 179-186
    • (2004) Technovation , vol.24 , pp. 179-186
    • Karlsson, M.1
  • 12
    • 0000967577 scopus 로고
    • A dual-core model of organizational innovation
    • Daft R.L. A dual-core model of organizational innovation. Acad. Manage. J. 21 (1978) 193-210
    • (1978) Acad. Manage. J. , vol.21 , pp. 193-210
    • Daft, R.L.1
  • 13
    • 23044491214 scopus 로고    scopus 로고
    • Optimizing the discovery organization for innovation
    • Sams-Dodd F. Optimizing the discovery organization for innovation. Drug Discov. Today 10 (2005) 1049-1056
    • (2005) Drug Discov. Today , vol.10 , pp. 1049-1056
    • Sams-Dodd, F.1
  • 15
  • 18
    • 0001812752 scopus 로고
    • Exploration and exploitation in organizational learning
    • March J.G. Exploration and exploitation in organizational learning. Organ. Sci. 2 (1991) 71-87
    • (1991) Organ. Sci. , vol.2 , pp. 71-87
    • March, J.G.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.